Research Roundup

Debbie Rigby rounds up the latest in research news Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Results from the STEP-HFpEF DM Trial show that semaglutide led to larger reductions in heart failure–related symptoms and physical limitations and greater weight loss than placebo at 1 year. Patients had heart failure with preserved

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Nurse fined following botox bust
Next No more aged care delays